HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(R)- 4- cyclopropyl- 7,8- difluoro- 5- (4- (trifluoromethyl)phenylsulfonyl)- 4,5- dihydro- 1H- pyrazolo(4,3- c)quinoline

gamma secretase inhibitor; structure in first source

Also Known As:

ELND006

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo(4,3-c)quinoline: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo(4,3-c)quinoline: 2

Experts

1.	Bullock, John: 1 article (04/2012)
2.	Goldbach, Erich: 1 article (04/2012)
3.	Gullapalli, Rampurna Prasad: 1 article (04/2012)
4.	Hoffman, Wherly: 1 article (04/2012)
5.	Liversidge, Gary G: 1 article (04/2012)
6.	Merisko-Liversidge, Elaine: 1 article (04/2012)
7.	Quinn, Kevin: 1 article (04/2012)
8.	Sauer, John-Michael: 1 article (04/2012)
9.	Tonn, George: 1 article (04/2012)
10.	Wong, Angelina: 1 article (04/2012)

Related Diseases

1.	Alzheimer Disease (Alzheimer's Disease) 04/01/2012 - "ELND006 is a novel gamma secretase inhibitor previously under investigation for the oral treatment of Alzheimer's disease. " 06/15/2011 - "ELND006 is a novel γ-secretase inhibitor by Elan Corporation that was in the clinic as a potential treatment for Alzheimer's disease (AD). "

Related Drugs and Biologics

1.	Amyloid Precursor Protein Secretases (beta-Secretase)